Exchange Traded Concepts LLC Buys 93 Shares of Humana Inc. (NYSE:HUM)

Exchange Traded Concepts LLC raised its holdings in Humana Inc. (NYSE:HUM) by 8.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,191 shares of the insurance provider’s stock after buying an additional 93 shares during the period. Exchange Traded Concepts LLC’s holdings in Humana were worth $302,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. FNY Investment Advisers LLC lifted its position in shares of Humana by 6,647.5% during the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock worth $6,916,000 after buying an additional 26,856 shares in the last quarter. PDT Partners LLC lifted its position in shares of Humana by 190.0% during the 3rd quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock valued at $1,286,000 after buying an additional 2,660 shares during the last quarter. Secure Asset Management LLC bought a new stake in shares of Humana in the fourth quarter valued at approximately $244,000. Ontario Teachers Pension Plan Board boosted its holdings in shares of Humana by 6.5% in the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock worth $371,705,000 after acquiring an additional 71,910 shares during the period. Finally, Swedbank AB lifted its holdings in Humana by 3.0% during the 3rd quarter. Swedbank AB now owns 105,976 shares of the insurance provider’s stock worth $33,567,000 after purchasing an additional 3,085 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Stock Down 1.2 %

Shares of Humana stock opened at $293.40 on Friday. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The company’s 50 day moving average is $275.45 and its 200 day moving average is $303.03. The company has a market cap of $35.33 billion, a price-to-earnings ratio of 25.99, a price-to-earnings-growth ratio of 2.22 and a beta of 0.55.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping the consensus estimate of $3.48 by $0.68. The firm had revenue of $29.30 billion for the quarter, compared to analysts’ expectations of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. Research analysts anticipate that Humana Inc. will post 16.11 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on HUM. Piper Sandler boosted their price target on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research report on Wednesday, January 15th. Stephens restated an “equal weight” rating and issued a $250.00 target price on shares of Humana in a report on Wednesday, October 9th. Royal Bank of Canada reduced their price target on Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. Barclays lifted their price objective on Humana from $253.00 to $255.00 and gave the company an “equal weight” rating in a research report on Wednesday, January 22nd. Finally, Truist Financial boosted their target price on shares of Humana from $260.00 to $290.00 and gave the company a “hold” rating in a report on Monday, January 6th. Nineteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Humana presently has an average rating of “Hold” and an average target price of $297.68.

Insider Transactions at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.32% of the stock is currently owned by company insiders.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.